Envista Holdings (NVST) Liabilities and Shareholders Equity (2018 - 2026)
Envista Holdings (NVST) posted quarterly Liabilities and Shareholders Equity of $5.6 billion for Q2 2026, up 2.04% year-over-year from $5.5 billion in Q2 2025, and down 1.78% quarter-over-quarter from $5.7 billion in Q4 2025.
Envista Holdings (NVST) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends
Envista Holdings' Liabilities and Shareholders Equity history runs 9 years deep, the most recent figure standing at $5.6 billion for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity rose 2.04% year-over-year to $5.6 billion; the TTM figure through Apr 2026 stood at $22.6 billion (up 3.67% YoY), while the FY2025 annual figure was $5.7 billion, up 6.14% from the prior year.
- Liabilities and Shareholders Equity for Q2 2026 stood at $5.6 billion, down from $5.7 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $6.7 billion in Q3 2023, with the low at $5.4 billion in Q4 2024.
- The 5-year median for Liabilities and Shareholders Equity is $6.4 billion (2022), against an average of $6.1 billion.
- The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity retreated 18.99% in 2024, then grew 6.14% in 2025.
- Envista Holdings' Liabilities and Shareholders Equity stood at $6.6 billion in 2022, then gained by 0.27% to $6.6 billion in 2023, then decreased by 18.99% to $5.4 billion in 2024, then rose by 6.14% to $5.7 billion in 2025, then retreated by 1.78% to $5.6 billion in 2026.
- Business Quant data shows NVST's Liabilities and Shareholders Equity at $5.6 billion in Q2 2026, $5.7 billion in Q4 2025, and $5.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 20.88 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 31.10 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 8.97 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 39.35 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 14.24 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 12.48 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 19.79 Bn |
| 10 | Envista Holdings | 4.40 Bn | 3.27 Bn | 407.00 Mn | 5.60 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 5.60 Bn |
| Apr 3, 2026 | 5.58 Bn |
| Dec 31, 2025 | 5.68 Bn |
| Sep 26, 2025 | 5.64 Bn |
| Jun 27, 2025 | 5.66 Bn |
| Mar 28, 2025 | 5.47 Bn |
| Dec 31, 2024 | 5.35 Bn |
| Sep 27, 2024 | 5.51 Bn |
| Jun 28, 2024 | 5.44 Bn |
| Mar 29, 2024 | 6.56 Bn |
| Dec 31, 2023 | 6.61 Bn |
| Sep 29, 2023 | 6.68 Bn |
| Jun 30, 2023 | 6.61 Bn |
| Mar 31, 2023 | 6.58 Bn |
| Dec 31, 2022 | 6.59 Bn |
| Sep 30, 2022 | 6.41 Bn |
| Jul 1, 2022 | 6.46 Bn |
| Apr 1, 2022 | 6.57 Bn |
| Dec 31, 2021 | 6.57 Bn |
| Oct 1, 2021 | 6.56 Bn |